Skip to content

Public FDA record

Z-1545-2024: CryoValve SG Cryopreserved Pulmonary Human Heart Valve

Recall record Z-1545-2024 for Artivion, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1545-2024
Company in FDA record
Artivion, Inc
FDA classification date
Apr 16, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The blood cultures performed as part of the organ donation process were positive for Staphylococcus aureus.

Source facts

Action
The single consignee was notified via email on 03/06/2024 with an amended letter sent on 03/14/2024. The first letter indicated to quarantine and return the affected unit, if not implanted. The consignee was requested to complete and return the response form.
Initiated
2024-03-06
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the state of Ohio.
Recall number
Z-1545-2024
Recall status
Open, Classified
CDRH record ID
206737
FDA classified
2024-04-16
Recall event number
94250

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗